Keyword: Washington University in St. Louis
Human-generated antibodies have provided new clues that could boost the development of a broadly protective antiviral drug and universal flu vaccine.
Researchers have developed a blood test that they say can be combined with genetic screening to predict Alzheimer's with 94% accuracy.
ALS patients on the highest dose of Biogen's tofersen (BIIB067) showed a slowdown in the progression of symptoms in a phase 1 trial.
The week’s biotech news included a surgical gel that prevents tumors from spreading and an antibody against opioids.
The past week’s biotech news included a method for regrowing nerves by turning off genes and a potential combo to treat resistant lung cancer.
The week’s biotech news included a mutation-targeting treatment for ALS and a malaria vaccine targeting a transmission protein.
Itaconate, a compound produced by inflammatory cells, relieved psoriasis-like symptoms in mice.
Instead of seeking the underlying cause of a group of symptoms, scientists started with a mutation and then tracked down people who have it.
The latest in biotech research includes a new way to grow human heart muscle and uncovering a genetic abnormality at the root of ALS and dementia.
Researchers at Washington University School of Medicine have found that targeting the APOE protein helps clear Alzheimer's plaques in mice.
